Skip to main content

Advertisement

SpringerLink
Log in

Mannan-binding lectin and ficolin deposition in skin lesions of pemphigus

  • Short Communication
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Pemphigus is characterized by circulating autoantibodies directed against desmossomal antigens that, once bound to target antigens, induce disruption in the cell–cell adhesion of the epidermis and mucosal epithelium, leading to blister formation. Evidence has indicated a role for complement in the physiopathology of pemphigus, with complement deposition in intercellular spaces of skin and mucous membrane lesions. Mannan-binding lectin (MBL) and Ficolin-2 are recognition proteins of innate immunity, which by binding to specific molecular patterns on pathogens surfaces trigger the activation of complement, leading to phagocytosis and lyses of target cells and inflammation. In this study we report for the first time the deposition of MBL and ficolins in pemphigus lesions. Eight biopsies of skin lesions of pemphigus vulgaris were studied for in situ deposition of IgG and the complement components MBL, Ficolin 1, Ficolin-2, C1q, C3 and membrane attack complex C5b-9. All biopsies presented deposition of IgG and C3 in the intercellular spaces (ICS) of epidermis. MBL deposition was found in the ICS and basal membrane zone (BMZ) of all specimens, whereas C5b-9 showed deposition only in the ICS, with irregular distribution. Ficolin-2 were positive in 50% (4/8) of biopsies showing deposition in the BMZ. On the other hand, ficolin-1 and C1q were negative in all specimens. Our study suggest that MBL and to a lesser extend Ficolin-2 may bind to altered intercellular structures in the skin and lead to the activation of complement in situ, contributing to tissue damage in pemphigus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Anhalt GJ, Diaz LA (2001) Prospects for autoimmune disease: Research advances in pemphigus. JAMA 285:652–654

    Article  PubMed  CAS  Google Scholar 

  2. Anhalt GJ, Till GO, Diaz LA, Labib RS, Patel HP, Eaglstein NF (1986) Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol 137:2835–2840

    PubMed  CAS  Google Scholar 

  3. Atkinson AP, Cedzynski M, Szemraj J, St Swierzko A, Bak-Romaniszyn L, Banasik M, Zeman K, Matsushita M, Turner ML, Kilpatrick DC (2004) l-ficolin in children with recurrent respiratory infections. Clin Exp Immunol 138:517–520

    Article  PubMed  CAS  Google Scholar 

  4. Cedzynski M, Szemraj J, Swierzko AS, Bak-Romaniszyn L, Banasik M, Zeman K, Kilpatrick DC (2004) Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol 136:304–311

    Article  PubMed  CAS  Google Scholar 

  5. Dornelles LN, Pereira-Ferrari L, Messias-Reason I (2006) Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms. Clin Exp Immunol 145:463–468

    Article  PubMed  CAS  Google Scholar 

  6. Hansen TK, Steffen T, Knudsen ST, Gravholt CH, Christiansen JS, Mogensen CE, Poulsen PL (2003) Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J Clin Endocrinol Metabol 88:4857–4861

    Article  CAS  Google Scholar 

  7. Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, Garred P (2005) Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet 14:1651–1658

    Article  PubMed  CAS  Google Scholar 

  8. Kawana S, Diaz LA, Rivitti EA, Geoghegan WD, Jordon RE (1988) Complement fixation by Brazilian Pemphigus foliaceus autoantibodies. Clin Exp Immunol 71(3):464–469

    PubMed  CAS  Google Scholar 

  9. Kawana S, Geoghegan WD, Jordon RE (1985) Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells. Clin Exp Immunol 61:517–525

    PubMed  CAS  Google Scholar 

  10. Kawana S, Geoghegan WD, Jordon RE, Nishiyama S (1989) Deposition of the membrane attack complex of complement in pemphigus vulgaris and pemphigus foliaceus skin. J Invest Dermatol 92:588–592

    Article  PubMed  CAS  Google Scholar 

  11. Kilpatrick DC (2002) Mannan-binding lectin and its role in innate immunity. Transfus Med 12:335–352

    Article  PubMed  CAS  Google Scholar 

  12. Lessey E, Li N, Diaz L, Liu Z (2008) Complement and cutaneous autoimmune blistering diseases. Immunol Res 41:223–232

    Article  PubMed  CAS  Google Scholar 

  13. Messias IT, Santamaria J, Ragiotto R, Doi EM, Kajdacsy-Balla A (1989) Complement activation in Brazilian pemphigus foliaceus. Clin Exp Dermatol 14:51–55

    Article  PubMed  Google Scholar 

  14. Messias IT, von Kuster LC, Santa Maria J, Kajdacsy-Balla A (1988) Complement and antibody deposition in Brazilian pemphigus foliaceus and correlation of disease activity with circulating antibodies. Arch Dermatol 124:1664–1668

    Article  PubMed  Google Scholar 

  15. Messias-Reason IJ, Boldt AB, Moraes Braga AC, Von Rosen SS, Dornelles L, Pereira-Ferrari L, Kremsner PG, Kun JF (2007) The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm. J Infect Dis 196:1379–1385

    Article  PubMed  Google Scholar 

  16. Messias-Reason IJ, Kremsner PG, Kun JF (2009) Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J Infect Dis 199:801–804

    Article  PubMed  Google Scholar 

  17. Messias-Reason IJ, Schafranski M, Jensenius JC, Sttefensen R (2006) The association between mannan-binding lectin gene polymorphism and rheumatic heart disease. Hum Immunol 67:991–998

    Article  PubMed  CAS  Google Scholar 

  18. Messias-Reason IJ, Schafranski MD, Kremsner PG, Kun JF (2009) Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease. Clin Exp Immunol 157:395–399

    Article  PubMed  CAS  Google Scholar 

  19. Messias-Reason I, Bosco DG, Nisihara RM, Jakobsen LH, Petzl-Erler ML, Jensenius JC (2008) Circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease 2 in endemic pemphigus foliaceus. Clin Exp Dermatol 33:495–497

    Article  PubMed  CAS  Google Scholar 

  20. Nisihara RM, Utiyama SR, Oliveira NP, Messias-Reason IJ (2010) Mannan-binding lectin deficiency increases the risk of recurrent infections in children with Down’s syndrome. Hum Immunol 71:63–66

    Article  PubMed  CAS  Google Scholar 

  21. Nelson KC, Zhao M, Schroeder PR, Li N, Wetsel RA, Diaz LA, Liu Z (2006) Role of different pathways of the complement cascade in experimental bullous pemphigoid. Clin Invest 116:2892–2900

    Article  CAS  Google Scholar 

  22. Petersen SV, Thiel S (2001) Jensenius JC The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 38:133–149

    Article  PubMed  CAS  Google Scholar 

  23. Schafranski MD, Stier A, Nisihara R, Messias-Reason IJT (2004) Significantly increased levels of mannose-binding lectin in rheumatic heart disease: a beneficial role for MBL deficiency. Clin Exp Immunol 138:521–525

    Article  PubMed  CAS  Google Scholar 

  24. Sitaru C, Mihai S, Zillikens D (2007) The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Arch Dermatol 299:1–8. doi:10.1007/s00403-007-0734-0

    Article  CAS  Google Scholar 

  25. Takahashi Y, Patel HP, Labib RS, Diaz LA, Anhalt GJ (1985) Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes. J Invest Dermatol 84:41–46

    Article  PubMed  CAS  Google Scholar 

  26. Xia P, Jordon RE, Geoghegan WD (1988) Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes. J Clin Invest 82:1939–1947

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to the Brazilian National Research Council CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico) for the Research Fellowship awarded to IJMR and to Prof. Dr. Marcos Randi for the pictures used in this study.

Author information

Authors and Affiliations

  1. Laboratory of Molecular Immunopathology, Department of Clinical Pathology, Hospital de Clínicas, Federal University of Paraná, Rua Padre Camargo, 280, 80.069-900, Curitiba, PR, Brazil

    Iara Jose de Messias-Reason, Renato Mitsunori Nisihara & Valmir Mocelin

Authors
  1. Iara Jose de Messias-Reason
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Renato Mitsunori Nisihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Valmir Mocelin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Iara Jose de Messias-Reason.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Messias-Reason, I.J., Nisihara, R.M. & Mocelin, V. Mannan-binding lectin and ficolin deposition in skin lesions of pemphigus. Arch Dermatol Res 303, 521–525 (2011). https://doi.org/10.1007/s00403-011-1132-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-011-1132-1

Keywords

Search

Navigation